RxDoctor Payments Data

Blake Doerr

Physician Assistant · Pensacola, FLNPI 1588345110

Payments from drug & device makers

$4,249in general payments, 2019–2025

Across 193 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$857
  • AstraZeneca$644
  • Sanofi$467
  • GSK$412
  • Amgen$284
  • Takeda Pharmaceuticals U.S.A., Inc.$214
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$4,06996%
  • Education$1804%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,249 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$39,098
Medicare patients
275
Services billed
3,610

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GammaplexImmun Glob G(Igg)/Gly/Iga 0-5011$89,348
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$25,710
SymbicortBudesonide/Formoterol Fumarate22$5,235
Breo ElliptaFluticasone/Vilanterol12$4,765
Cromolyn Sodium13$3,339
Arnuity ElliptaFluticasone Furoate14$3,117
Ipratropium Bromide104$3,037
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$3,029
Azelastine Hcl58$1,839
Fluticasone Propionate48$1,231
Montelukast Sodium64$1,048
Albuterol Sulfate HfaAlbuterol Sulfate30$721
Wixela InhubFluticasone Propion/Salmeterol12$699
Ventolin HfaAlbuterol Sulfate13$686
Levocetirizine Dihydrochloride18$323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$412$33,59260 claims
AstraZenecaSymbicort$644$5,23522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →